• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2012-2015 年南非肺炎支原体的流行病学和分子鉴定及特征分析。

Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.

出版信息

Emerg Infect Dis. 2018 Mar;24(3):506-513. doi: 10.3201/eid2403.162052.

DOI:10.3201/eid2403.162052
PMID:29460736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5823326/
Abstract

During 2012-2015, we tested respiratory specimens from patients with severe respiratory illness (SRI), patients with influenza-like illness (ILI), and controls in South Africa by real-time PCR for Mycoplasma pneumoniae, followed by culture and molecular characterization of positive samples. M. pneumoniae prevalence was 1.6% among SRI patients, 0.7% among ILI patients, and 0.2% among controls (p<0.001). Age <5 years (adjusted odd ratio 7.1; 95% CI 1.7-28.7) and HIV infection (adjusted odds ratio 23.8; 95% CI 4.1-138.2) among M. pneumonia-positive persons were associated with severe disease. The detection rate attributable to illness was 93.9% (95% CI 74.4%-98.5%) in SRI patients and 80.7% (95% CI 16.7%-95.6%) in ILI patients. The hospitalization rate was 28 cases/100,000 population. We observed the macrolide-susceptible M. pneumoniae genotype in all cases and found P1 types 1, 2, and a type 2 variant with multilocus variable number tandem repeat types 3/6/6/2, 3/5/6/2, and 4/5/7/2.

摘要

在 2012 年至 2015 年期间,我们通过实时 PCR 对南非患有严重呼吸道疾病(SRI)、流感样疾病(ILI)的患者和对照者的呼吸道标本进行了肺炎支原体检测,然后对阳性样本进行培养和分子特征分析。肺炎支原体在 SRI 患者中的流行率为 1.6%,ILI 患者中为 0.7%,对照组中为 0.2%(p<0.001)。肺炎支原体阳性者中年龄<5 岁(调整后的优势比 7.1;95%CI 1.7-28.7)和 HIV 感染(调整后的比值比 23.8;95%CI 4.1-138.2)与严重疾病相关。在 SRI 患者中,归因于疾病的检测率为 93.9%(95%CI 74.4%-98.5%),在 ILI 患者中为 80.7%(95%CI 16.7%-95.6%)。住院率为每 100,000 人口 28 例。我们在所有病例中均观察到了对大环内酯类敏感的肺炎支原体基因型,并发现了 P1 型 1、2 型和 2 型变体,其多位点可变数串联重复类型为 3/6/6/2、3/5/6/2 和 4/5/7/2。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90fa/5823326/6f9fffb5a4e5/16-2052-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90fa/5823326/6f9fffb5a4e5/16-2052-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90fa/5823326/6f9fffb5a4e5/16-2052-F.jpg

相似文献

1
Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.2012-2015 年南非肺炎支原体的流行病学和分子鉴定及特征分析。
Emerg Infect Dis. 2018 Mar;24(3):506-513. doi: 10.3201/eid2403.162052.
2
Molecular Typing of Strains in Sweden from 1996 to 2017 and the Emergence of a New P1 Cytadhesin Gene, Variant 2e.1996 年至 2017 年瑞典分离株的分子分型及新型 P1 细胞黏附素基因变体 2e 的出现。
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.00049-19. Print 2019 Jun.
3
Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013.美国肺炎支原体感染调查:2006年至2013年分子分型及大环内酯类耐药性趋势
J Clin Microbiol. 2015 Jan;53(1):124-30. doi: 10.1128/JCM.02597-14. Epub 2014 Oct 29.
4
Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.香港大环内酯类耐药肺炎支原体的出现与多位点可变数目串联重复序列分析4-5-7-2型中不断增加的大环内酯类耐药性有关。
J Clin Microbiol. 2015 Nov;53(11):3560-4. doi: 10.1128/JCM.01983-15. Epub 2015 Sep 2.
5
Molecular Characterization of Mycoplasma pneumoniae Infections in Two Rural Populations of Thailand from 2009 to 2012.2009年至2012年泰国两个农村地区肺炎支原体感染的分子特征
J Clin Microbiol. 2017 Jul;55(7):2222-2233. doi: 10.1128/JCM.00350-17. Epub 2017 May 10.
6
Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome.肺炎支原体相关史蒂文斯-约翰逊综合征暴发期间肺炎支原体的流行病学及分子特征
Pediatr Infect Dis J. 2017 Jun;36(6):564-571. doi: 10.1097/INF.0000000000001476.
7
Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.对中国流行期间各年龄段社区获得性肺炎患者肺炎支原体的分子特征分析和研究。
Int J Infect Dis. 2019 Jun;83:26-31. doi: 10.1016/j.ijid.2019.03.028. Epub 2019 Mar 26.
8
Molecular characterization of genomic DNA in mycoplasma pneumoniae strains isolated from serious mycoplasma pneumonia cases in 2016, Yunnan, China.2016 年中国云南严重肺炎支原体感染病例中分离的肺炎支原体菌株的基因组 DNA 的分子特征。
Infect Genet Evol. 2018 Mar;58:125-134. doi: 10.1016/j.meegid.2017.12.020. Epub 2017 Dec 22.
9
Multilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002-2016.2002-2016 年日本肺炎支原体多位点序列分型。
Emerg Infect Dis. 2018 Oct;24(10):1895-1901. doi: 10.3201/eid2410.171194.
10
Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.2006 年至 2014 年斯洛文尼亚中部分离的呼吸道感染患者肺炎支原体的流行率、基因分型和大环内酯类耐药性。
Euro Surveill. 2015;20(37). doi: 10.2807/1560-7917.ES.2015.20.37.30018.

引用本文的文献

1
P1 adhesin genotype characteristics of in China from 2017 to 2019.2017年至2019年中国[具体对象]的P1黏附素基因型特征 。 (你提供的原文有缺失信息,推测这里应该有个具体是关于什么的P1 adhesin genotype characteristics,比如某种细菌等,但按现有内容翻译如上)
Front Cell Infect Microbiol. 2025 Feb 17;15:1513177. doi: 10.3389/fcimb.2025.1513177. eCollection 2025.
2
The Clinical Value of Novel Inflammatory Biomarkers for Predicting Mycoplasma pneumoniae Infection in Children.新型炎症生物标志物对预测儿童支原体肺炎感染的临床价值
J Clin Lab Anal. 2025 Feb;39(3):e25150. doi: 10.1002/jcla.25150. Epub 2025 Jan 12.
3
A comparative study of general and severe mycoplasma pneumoniae pneumonia in children.

本文引用的文献

1
Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia.采用 TaqMan 阵列卡鉴定社区获得性肺炎住院患者肺炎支原体合并细菌和病毒感染。
Open Forum Infect Dis. 2016 Mar 30;3(2):ofw071. doi: 10.1093/ofid/ofw071. eCollection 2016 Mar.
2
Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States.美国社区获得性肺炎住院患者中肺炎支原体的分子检测与特征分析。
Open Forum Infect Dis. 2015 Jul 16;2(3):ofv106. doi: 10.1093/ofid/ofv106. eCollection 2015 Sep.
3
儿童普通型与重症肺炎支原体肺炎的对比研究。
BMC Infect Dis. 2024 Apr 26;24(1):449. doi: 10.1186/s12879-024-09340-x.
4
Systematic review and meta-analysis on the etiology of bacterial pneumonia in children in sub-Saharan Africa.撒哈拉以南非洲儿童细菌性肺炎病因的系统评价与荟萃分析。
J Public Health Afr. 2022 Sep 29;13(3):2151. doi: 10.4081/jphia.2022.2151. eCollection 2022 Sep 7.
5
Mycoplasma pneumoniae among Hospitalized Patients with Acute Respiratory Tract Infections in an Indian Tertiary Care Hospital: an Underreported Health Problem.印度一家三级保健医院急性呼吸道感染住院患者中肺炎支原体感染:一个漏报的健康问题。
Microbiol Spectr. 2022 Aug 31;10(4):e0158922. doi: 10.1128/spectrum.01589-22. Epub 2022 Jul 14.
6
Laboratory analysis of positive rate of antibody among 53,273 children with respiratory tract infections in Xi'an from 2017 to 2020.2017年至2020年西安市53273例呼吸道感染儿童抗体阳性率的实验室分析。
Transl Pediatr. 2022 May;11(5):625-630. doi: 10.21037/tp-22-127.
7
Etiology and efficacy of anti-microbial treatment for community-acquired pneumonia in adults requiring hospital admission in Ukraine.乌克兰成人社区获得性肺炎住院患者抗微生物治疗的病因和疗效。
Acta Biomed. 2022 May 11;93(2):e2022238. doi: 10.23750/abm.v93i2.13137.
8
Pulmonary and Extrapulmonary Manifestations in Hospitalized Children with Mycoplasma Pneumoniae Infection.住院支原体肺炎感染患儿的肺内和肺外表现
Microorganisms. 2021 Dec 10;9(12):2553. doi: 10.3390/microorganisms9122553.
9
Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines.儿童社区获得性肺炎的诊断与管理:南非胸科学会指南
Afr J Thorac Crit Care Med. 2020 Oct 13;26(3). doi: 10.7196/AJTCCM.2020.v26i3.104. eCollection 2020.
10
Community-acquired pneumonia: The need to broaden our diagnostic armamentarium.社区获得性肺炎:拓宽我们诊断手段的必要性。
Afr J Thorac Crit Care Med. 2020 Mar 19;26(1). doi: 10.7196/AJTCCM.2020.v26i1.063. eCollection 2020.
Macrolide-Resistant Mycoplasma pneumoniae, United States.
美国耐大环内酯类肺炎支原体
Emerg Infect Dis. 2015 Aug;21(8):1470-2. doi: 10.3201/eid2108.150273.
4
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.美国成年人中需要住院治疗的社区获得性肺炎
N Engl J Med. 2015 Jul 30;373(5):415-27. doi: 10.1056/NEJMoa1500245. Epub 2015 Jul 14.
5
Community-acquired pneumonia requiring hospitalization among U.S. children.美国儿童中需要住院治疗的社区获得性肺炎。
N Engl J Med. 2015 Feb 26;372(9):835-45. doi: 10.1056/NEJMoa1405870.
6
Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.2011 - 2012年德国社区获得性肺炎中的肺炎支原体和衣原体属感染
Emerg Infect Dis. 2015 Mar;21(3):426-34. doi: 10.3201/eid2103.140927.
7
Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013.美国肺炎支原体感染调查:2006年至2013年分子分型及大环内酯类耐药性趋势
J Clin Microbiol. 2015 Jan;53(1):124-30. doi: 10.1128/JCM.02597-14. Epub 2014 Oct 29.
8
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis.2000-13 年全球、区域和国家儿童死亡原因及其对 2015 年后重点的影响:更新系统分析。
Lancet. 2015 Jan 31;385(9966):430-40. doi: 10.1016/S0140-6736(14)61698-6. Epub 2014 Sep 30.
9
Childhood pneumonia in developing countries.发展中国家的儿童肺炎。
Lancet Respir Med. 2013 Sep;1(7):574-84. doi: 10.1016/S2213-2600(13)70075-4. Epub 2013 Jun 18.
10
Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university.一所大学呼吸道疾病暴发期间肺炎支原体的检测与特征分析
J Clin Microbiol. 2014 Mar;52(3):849-53. doi: 10.1128/JCM.02810-13. Epub 2013 Dec 26.